Study to evaluate efficacy and safety of imiglucerase treatment in Chinese patients with Gaucher disease type Ⅲ

Trial Identifier: LPS16031
Sponsor: Sanofi
Start Date: March 2021
Primary Completion Date: October 2023
Study Completion Date: October 2023
Condition: Gaucher Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
CHINA Beijing, CHINA, 100020
CHINA Beijing, CHINA, 100032
CHINA Chengdu, CHINA, 610041
CHINA Guangzhou, CHINA, 510080
CHINA Guangzhou, CHINA, 510623